Talk:Hyperimmune globulin

Merger discussion
Most of the sources I can find on this topic seem to treat Hyperimmune globulin therapy as a subset of immunoglobulin therapies, rather than something distinct. NickCT (talk) 10:48, 11 May 2020 (UTC)
 * Agree. However, the Ig therapy page currently treats normal human immunoglobulin as an alias. Merging is illogical without splitting that medication out. --Artoria2e5 🌉 13:12, 16 December 2020 (UTC)
 * ✅ Klbrain (talk) 14:04, 15 May 2021 (UTC)
 * Oppose the proposed split; I think that the fist sentence was misleadingly written to confuse the treatment with the immunoglobulin preparation. Not that that has been fixed (my edit), I don't think that there is a need for the split. The preparation and the therapy are best discussed together. Klbrain (talk) 14:06, 15 May 2021 (UTC)